Marshall University

Marshall Digital Scholar
Biochemistry and Microbiology

Faculty Research

9-1-2011

Domain Requirements for the Diverse Immune
Regulatory Functions of Foxp3
Wei-ping Zeng
Marshall University, zengw@marshall.edu

Vincent E. Sollars
Marshall University, sollars@marshall.edu

Andrea Del Pilar Belalcazar

Follow this and additional works at: http://mds.marshall.edu/sm_bm
Part of the Biological Phenomena, Cell Phenomena, and Immunity Commons, Medical
Biochemistry Commons, and the Medical Immunology Commons
Recommended Citation
Zeng WP, Sollars VE, Belalcazar AP. Domain requirements for the diverse immune regulatory functions of foxp3. Molecular
Immunology. 2011 Sep;48(15-16): 1932-9.

This Article is brought to you for free and open access by the Faculty Research at Marshall Digital Scholar. It has been accepted for inclusion in
Biochemistry and Microbiology by an authorized administrator of Marshall Digital Scholar. For more information, please contact
zhangj@marshall.edu.

Molecular Immunology 48 (2011) 1932–1939

Contents lists available at ScienceDirect

Molecular Immunology
journal homepage: www.elsevier.com/locate/molimm

Domain requirements for the diverse immune regulatory functions of foxp3夽
Wei-ping Zeng ∗ , Vincent E. Sollars, Andrea Del Pilar Belalcazar
Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University, 1 John Marshall Drive, Huntington, WV 25701, United States

a r t i c l e

i n f o

Article history:
Received 16 March 2011
Received in revised form 20 May 2011
Accepted 24 May 2011
Available online 6 July 2011
Keywords:
Foxp3
Treg cells
Mutagenesis
Autoimmunity
Th1/Th2 cells

a b s t r a c t
Foxp3 is responsible for the major immunological features of Treg cells, including hypoproliferation in
vitro, immune suppression of conventional T cells and resistance to Th2 cell differentiation. In addition to
the Forkhead domain, the Foxp3 protein contains the N-terminal, zinc ﬁnger and leucine zipper domains.
To understand how these domains contribute to Foxp3 functions, we systematically compared the roles
of these domains in determining the 3 major immunological features of Treg cells. We designed a bridgemediated mutagenesis method to generate Foxp3 mutants with complete deletion of each of the domains.
CD4 T cells expressing the Foxp3 mutant with deletion of the N-terminal, leucine zipper or the forkhead
domain showed robust TCR dependent proliferation in vitro, differentiated into Th2 cells, and lost immune
suppressive activities in vitro and in vivo, demonstrating a complete loss of all 3 functions of Foxp3.
In contrast, deletion of the zinc ﬁnger domain only partially impaired these functions of Foxp3. This
result suggests that mutations in the zinc ﬁnger domain could lead to nonlethal autoimmune and allergic
diseases, in which reduction rather than complete loss of Foxp3 functions is expected. In any case, deletion
of a particular domain showed similar effects on all 3 functions of Foxp3. Therefore deﬁning each of the
immunological features of Treg cells requires intact Foxp3 proteins.
© 2011 Elsevier Ltd. All rights reserved.

1. Introduction
Thymus-derived natural Treg (nTreg) cells and inducible Treg
(iTreg) cells derived from peripheral conventional CD4 T (CD4 Tcon)
cells play critical roles in preventing autoimmune and allergic diseases (Chen et al., 2003; Sakaguchi et al., 1995). These important
functions of Treg cells are attributed to the fact that Treg cells can
inhibit the activation of CD4 and CD8 Tcon cells, which can be
measured by the inhibition of Tcon cell proliferation in response
to TCR stimulation (Piccirillo and Shevach, 2001; Thornton and
Shevach, 1998) in vitro and IBD in vivo (Hori et al., 2003; Read
et al., 2000). Treg cells not only inhibit the proliferation of Tcon cells,
but they themselves do not proliferate in response to TCR stimulation in vitro (Thornton and Shevach, 1998) although the Treg cells
can readily proliferate in response to antigen stimulation in vivo
(Walker et al., 2003).
Another important feature of nTreg cells is that their TCR show
high afﬁnities to self antigens (Andersson et al., 2007; Hsieh et al.,

Abbreviations: Th, T helper; MFI, mean ﬂuorescence intensity; IPEX, immune
dysfunction polyendocrinopathy enteropathy X-linked syndrome; IBD, inﬂammatory bowel diseases.
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2004). While the self reactivity is important for the development
of nTreg cells (Jordan et al., 2001) and efﬁcient activation of the
suppressive function of Treg cells against auto-reactive Tcon cells,
it also creates a dilemma that Treg lineage cells may cause autoimmunity if they gain Th effector functions. In this regard, early studies
found that Treg cells were incapable of producing Th1 and Th2
cytokines (Chen et al., 2006; Hori et al., 2003). However, more
recent studies including those of our own have shown that Treg
cells can produce the Th1 cytokine IFN-␥ (Kitoh et al., 2009; Wei
et al., 2009; Zeng et al., 2009). It has also been shown that Treg
cells with reduced expression of Foxp3 due to genetic modiﬁcations or homeostatic expansion in lymphopenic hosts can produce
IL-4 (Kitoh et al., 2009; Wan and Flavell, 2007; Wang et al., 2010).
On the other hand, human Treg cells, mainly those that have lost
Foxp3 expression, can differentiate into Th17 cells (Valmori et al.,
2010). Nonetheless, we and others found that that murine Treg cells
that maintained normal expression of Foxp3 could not produce Th2
or Th17 cytokines (Kitoh et al., 2009; Komatsu et al., 2009; Wan
and Flavell, 2007; Zeng et al., 2009). Thus, resistance to Th2 and
Th17 differentiation, hypo-proliferation in vitro and immune suppression, constitute the 3 major immunological features of Treg
cells.
How these features of Treg cells are determined at the molecular level is not well understood. It is known that the transcription
factor Foxp3 is responsible for immune suppression and hypoproliferation in vitro (Hori et al., 2003). For the regulation of Th
subset differentiation, high-level expression of Foxp3 is sufﬁcient to
block Th2 cell differentiation, but Foxp3 alone only partially inhibits
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Fig. 1. Generation of Foxp3 mutants. (A) Basic design of bridge-mediated mutagenesis (example of ZnF mutant). Domain organization of the mouse Foxp3 cDNA cloned in
the MigR1 vector is shown at the top. NT, N-terminal domain; ZnF, zinc ﬁnger domain; Zipper, leucine zipper domain; thick line, noncoding cDNA of Foxp3; thin line, partial
sequences of MigR1 vector. The horizontal arrowheads depict the primer locations used in the ﬁrst round of PCR to amplify the DNA fragments either 5 (primers RV5 and
ZincB) or 3 (ZincF and 1545B) for producing the zinc ﬁnger domain deletion mutant. These 2 fragments are joined together by a second round of PCR using the ampliﬁcation
primers RV5 and 1545B, and the bridge oligo ZincDel. The positions of the oligos are shown schematically. (B) Left, the 5 and 3 fragments for producing Foxp3 mutants
with deletion of the N-terminal (NT), the zinc ﬁnger (ZnF), the leucine zipper (Zip), or the forkhead (Fkh) domain were generated in the ﬁrst round of PCR. Right,
full-length Foxp3 mutants were produced in the second round of PCR by joining the DNA fragments from the ﬁrst PCR. (C) The wild type and domain deletion mutant Foxp3
fused with a tag containing the protein A IgG binding motifs were retrovirally expressed in CD4 T cells. The Western blots of the infected CD4 T cell lysates are shown. In the
upper panel, the blot was probed with the peroxidase-anti-peroxidase IgG complex (PAP) that binds to the tag. In the lower panel, the blot was probed with anti-actin IgG.

Th17 differentiation (Kwon et al., 2008; Zeng et al., 2009). Consistent with the ability of nTreg cells to differentiate into “Th1 cells,
Foxp3 does not affect Th1 differentiation (Zeng et al., 2009). These
data show that almost all of the immunological features of Treg cells
can be recapitulated by expressing Foxp3 in CD4 T cells. Therefore,
dissecting the modes of action of Foxp3 is critical to understanding the molecular basis for the immunological features of Treg
cells.
Mutations in the Foxp3 gene are responsible for the lethal
autoimmune and allergic disorders in the scurfy mouse and the
IPEX patients (Brunkow et al., 2001; Chatila et al., 2000). Foxp3 is a
transcription factor featured with a DNA-binding forkhead domain
at the C-terminus. The scurfy mouse phenotype is due to an insertion mutation in the Foxp3 gene that results in a truncated protein
that lacks the forkhead domain, and the mutations for IPEX syndromes in humans are also concentrated in the forkhead domain
(Brunkow et al., 2001; Gambineri et al., 2003; Lopes et al., 2006).
Based on the X-ray crystal structure of the forkhead domain, Wu
et al. (2006) have identiﬁed key amino acid residues in the forkhead domain for Foxp3 function. Outside the forkhead domain,
amino acid sequence analysis reveals that the Foxp3 protein contains 2 well-structured domains, the leucine zipper and zinc ﬁnger
domains, and the less structured N-terminal domain/region (Fig. 1).
Several studies have found that the leucine zipper domain is important for the dimerization of Foxp3, and the N-terminal region has
an intrinsic transcriptional repressor activity (Chae et al., 2006; Li
et al., 2007; Lopes et al., 2006). However, systematic analyses and
comparison of the immune regulatory functions of these domains
have been lacking. It is not clear whether the Foxp3 protein functions in a modular fashion such that the different domains control
a different feature of the Treg cells or they function in unison to
deﬁne all the major immunological features of the Treg cells. In the
current study, we generated Foxp3 mutants with deletion of each
of the domains of Foxp3, and systematically compare the effects of
each deletion on the 3 major immunological features of the Treg
cells.

2. Materials and methods
2.1. Mice
Balb/c and C.B-17.Scid mice were purchased from NCI, and bred
in Marshall University Animal Facility. Balb/c.Thy1.1 mice were
obtained from Dr. D. Fowell at the University of Rochester, and a
colony was maintained at the Marshall University Animal Facility. All animal studies were approved by the Marshall University
IACUC.
2.2. Plasmid and mutagenesis
MigR1.mFoxp3 plasmid was a gift from Dr. S. Sakaguchi, and the
MigR1 retroviral vector was a gift from Dr. W. Pear. A tandem afﬁnity puriﬁcation tag containing 2 tandem repeats of protein A IgG
binding motifs was cloned to the MigR1 vector to generate MigR1
Tag. The coding region of the wild type Foxp3 cDNA was PCR ampliﬁed using MigR1 mFoxp3 as template, and cloned to MigR1 Tag with
its C-terminus in-framed fused with the tag. Foxp3 mutants with
deletion of each of the N-terminal, the zinc ﬁnger and the leucine
zipper domains were generated by “bridge-mediated” mutagenesis as described in Section 3. Oligos and their sequences used
for mutagenesis are listed in Table S1 in Supplementary Materials.
2.3. Cell culture and retroviral infection
CD4 T cells were isolated from spleen and lymph node cells
by depleting CD8 T cells, B cells and other MHC class II antigen+
cells with magnetic beads. CD4 T cells were cultured in RPMI1640 containing 10% heat inactivated fetal bovine serum (FBS) and
recombinant human IL-2 (100 U/ml), and activated by anti-CD3
antibody (0.5 g/ml) plus mitomycin treated APC (T cell depleted
spleen cells). After 20 h of activation, the cells were infected
with retrovirus. Preparation of retrovirus expressing Foxp3 and
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its mutants and infection of T cells were carried out as previously
described (Mikhalkevich et al., 2006; Zheng et al., 2004). Retrovirally infected cells were isolated by FACS sorting of CD4+ GFP+ cells.
In some cases, the sorted cells were subject to second round of stimulation under conditions for Th1 or Th2 differentiation as described
in earlier studies (Zhao et al., 2007).
2.4. Western blot
Two million CD4 T cells retrovirally expressing the wild type
Foxp3 or its domain deletion mutants fused with the tag were lysed
in 200 l cell lysis buffer (300 mM NaCl, 1% Triton-X100, 10 mM
Tris–HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.2 mM Na3 VO4 , 0.5%
NP-40, 1 mM NaF) supplemented with complete protease inhibitor
(Roche, Indianapolis). The lysates were fractionated by SDS-PAGE.
Western blot was probed with peroxidase-anti-peroxidase Ab complex (PAP) (Sigma), which binds to the tag.
2.5.

3 H-thymidine

incorporation assay

CD4 T cells and APC were mixed at 1:1 ratio at 2 × 105 /ml
in RPMI-1640 plus 10% FBS and anti-CD3 antibody (0.5 g/ml).
The mixture was added in triplicates to U-bottom 96-well plate
(200 l/well) and incubated for 3 days before cell harvesting. 3 Hthymidine (1 Ci/well) was added to the culture 18 h prior to
cell harvest. Cells were harvested with a Filtermate Harvester
(Packard), and 3 H-thymidine incorporation was detected by a 1450
Microbeta Plus liquid scintillation counter (PerkinElmer).
2.6. RT-PCR
CD4+ CD25hi T cells and CD4+ CD25− T cells retrovirally expressing Foxp3 ZnF were isolated by FACS. Total RNA was extracted
from these cells using UltraspecTM -II RNA Isolation System (Biotecx
Laboraoreis, Inc.), and used for cDNA synthesis using oligo dT
primer and Superscript RT III (Invitrogen). PCR primer sequences
for Tubb5 and endogenous Foxp3 are as follows. Tubb5.211F: gac
cga atc tct gtg tac tat aat g, Tubb5.338B: cca gac tga ccg aaa acg aag
t; Foxp3.1601F: cca aaa cca tga gac tga ggc t, Foxp3.1756B: tgg cac
ccc tct cag ctg taa g (derived from the 3 untranslated region).
2.7. CFSE assay
Balb/c.Thy1.1 CD4 T cells labeled with CFSE (2 × 105 /ml) were
activated with anti-CD3 antibody (0.5 g/ml) plus APC in the
absence or presence of equal number of Balb/c CD4 T cells retrovirally expressing the wild type Foxp3 or its domain deletion
mutants. On day 4 of activation, the cells were stained with
APC-conjugated anti-CD4 and PE-Cy5 conjugated anti-Thy1.1 antibodies (BD Pharmingen). Dilution of CFSE in the CD4+ Thy1.1+ cells
was measured by ﬂow cytometry. Division index is calculated
as (100 − Y)/Y, where Y (%) = D0 + D1/21 + D2/22 + · · · + Dn/2n (Dn = %
cells that have undergone n divisions) (Angulo and Fulcher, 1998).
Statistical signiﬁcance of division index was analyzed by Student’s
t test.
2.8. Induction of IBD
CD4+ CD25− CD45RBhigh cells of Balb/c origin were isolated by
FACS sorting. The sorted cells (4 × 105 /mouse) were i.v. injected
into C.B-17 Scid mice either alone or together with Balb/c CD4 T cells
retrovirally expressing the wild type or domain deletion mutants of
Foxp3 (1 × 106 /mouse). Two months after adoptive transfer, colons
of the recipient mice were analyzed by histology (H&E staining).

Colitis scores were determined as previously described (Read and
Powrie, 2001).
2.9. Chromatin immunoprecipitation (ChIP)
CD4 T cells were retrovirally transfected with wild type or
mutant Foxp3 fused with the Tag. After 5 days of culture, the
cells were rested then stimulated with PMA (50 ng/ml) and ionomycin (1 M) for 4 h. ChIP was carried as previously described
(Hamalainen-Laanaya et al., 2007). After soniﬁcation, the chromatin fragments were precipitated with IgG-conjugated sepharsoe
beads (GE Healthcare), and digested with proteinase K. Chromatin DNA was puriﬁed by phenol–chloroform extract and ethanol
precipitation. The amounts of the Foxp3 target sequence in the
chromatin DNA were determined by real-time PCR using primers
IL2-97F (AGCCCACACTTAGGTGGCAGT) and IL2-251B (TGTCCACCACAACAGGCTGCT) that encompass the murine IL-2 ARRE site (Jain
et al., 1993; Wu et al., 2006). The ampliﬁcation signals were normalized to input chromatin DNA, and the relative ampliﬁcations
were determined by comparing to that of CD4 T cells transduced
with the Tag only by the 2−Ct method (Livak and Schmittgen,
2001).
3. Results
3.1. Generation of Foxp3 domain deletion mutants by
“bridge-mediated mutagenesis”
To systematically compare the roles of the 3 domains of Foxp3
outside the forkhead domain (Fkh), we generated Foxp3 mutants
with complete deletion of each of the 3 domains, the N-terminal
(NT), zinc ﬁnger (ZnF) and leucine zipper (Zip) domains. We
also generated a mutant with deletion of the Fkh domain as a
control for our studies. Unlike point mutation and small insertion/deletions, where residual functions of the domain may persist,
complete deletion allows for full assessment of the functions of a
particular domain.
We designed a PCR-based mutagenesis method called bridgemediated mutagenesis to generate the mutants. Fig. 1A illustrates
the basic design of the method using deletion of the zinc ﬁnger
domain as an example. The mutant DNA was generated by 2 rounds
of PCR. In the ﬁrst round of PCR, the DNA fragments immediately
upstream and downstream of the zinc ﬁnger domain were ampliﬁed by PCR. These 2 fragments served as the templates for the
second round of PCR, and the forward primer for 5 fragment (RV5)
and the backward primer for the 3 fragment (1545B) were used as
the ampliﬁcation primers. A “bridge oligo” delZnF hybridizing to the
3 and 5 ends of the upstream and downstream fragments, respectively, was used at low molarity (1/10 of the ampliﬁcation primers)
to “connect” the 5 and 3 fragments in the second round of PCR.
The second round of PCR generated the Foxp3 cDNA fragment with
speciﬁc deletion of zinc ﬁnger domain as the major product. This
mutant fragment was cloned in frame with a tag of protein A IgG
binding motifs in the retroviral vector MigR1. In addition to deletion, similar strategies can be used for point mutation and insertion
mutagenesis (Fig. S1).
Using this mutagenesis method, we successfully generated the
NT, ZnF, Zip and Fkh Foxp3 mutants (Fig. 1B). DNA sequencing results conﬁrmed the precise deletion of the speciﬁc domain
in each mutant (Fig. S2). Each of these mutants, as well as the
wild type Foxp3, was expressed in CD4 T cells by retroviral infection. The mutant and wild type Foxp3 proteins were detected in
Western blot probed with the peroxidase-anti-peroxidase Ab complex (PAP), which binds to the tag of protein A IgG binding motifs
(Fig. 1C).
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Fig. 2. Effects of domain deletion Foxp3 mutants on the proliferative response of CD4 T cells to anti-CD3 stimulation in vitro. (A) CD4 T cells from Balb/c mice were stimulated
with anti-CD3 Ab plus APC (T cell-depleted spleen cells). One day after stimulation, the cells were infected with retrovirus co-expressing GFP and the wild type Foxp3 or the
indicated domain deletion mutant. The infected cells (CD4+ GFP+ ) were isolated by FACS, and expanded in vitro for 6 days. Afterwards, the cells were rested overnight, then
stimulated with anti-CD3 Ab plus APC. Plot shows the cell proliferation as measured by 3 H-thymidine incorporation after 3 days of culture. Student t test shows signiﬁcant
difference between CD4 T cells expressing the zinc ﬁnger deletion Foxp3 mutant (ZnF) and cells expressing the tag only. Two of 3 independent studies are shown. (B)
RT-PCR analysis of endogenous Foxp3 expression. Total RNA was extracted from fresh isolated CD4+ CD25hi T cells or CD4+ CD25− T cells expressing retroviral Foxp3 ZnF.
Tubb5: ␤ tubulin 5 gene. (C) Histogram plots showing the levels of retroviral GFP in FACS sorted CD4 T cells infected with the indicated wild type or mutant Foxp3.

3.2. In vitro proliferation of CD4 T cells expressing the Foxp3
mutants
When expressed in CD4 Tcon cells, Foxp3 causes hypoproliferation of the CD4 Tcon cells in response to stimulation with anti-CD3
Ab plus APC (Hori et al., 2003). To examine the effects of deletion
of each of the domains on CD4 T cell proliferation, we infected
CD4 T cells with retrovirus expressing the tag only, the wild type
Foxp3 or a domain deletion mutant Foxp3. The infected CD4 T
cells were isolated by FACS sorting of the CD4+ GFP+ cells, and
expanded once. The cells were then stimulated with anti-CD3 Ab
plus APC, and proliferation was measured by H3 -thymidine incorporation (Fig. 2A). As expected, CD4 T cells expressing the wild
type Foxp3 showed little proliferation, whereas cells expressing the
Fkh mutant showed robust proliferation. CD4 T cells expressing
the NT or Zip mutant showed proliferation levels comparable
to that of the CD4 T cells expressing only the tag. Interestingly, however, expressing the ZnF mutant in CD4 T cells led to signiﬁcant
reduction of proliferation. These results demonstrated that the zinc
ﬁnger domain is only partially required for the hypoproliferation
caused by Foxp3. Although unlikely, it was possible that the reduction of proliferation of the ZnF mutant-expressing cells was due to
induction of endogenous Foxp3. To test this, we analyzed endogenous Foxp3 expression by RT-PCR using primers derived from the 3
untranslated region of the Foxp3 cDNA that was not present in the
retroviral Foxp3 and the ZnF mutant. As expected, we detected
endogenous Foxp3 in fresh isolated CD25+ CD4 T cells but not in the
CD25− CD4 T cells expressing the retroviral ZnF mutant (Fig. 2B).
The differences among the wild type and mutant Foxp3 was not
due to different levels of retroviral expression as similar levels of
GFP expression were detected (Fig. 2C).
3.3. Inhibition of in vitro proliferation of responder CD4 T cells
Retroviral expression of Foxp3 in conventional CD4 T cells converts the cells to Treg cells that inhibit the proliferation of responder
CD4 T cells in vitro (Hori et al., 2003). To determine the domain
requirement for this aspect of Foxp3 function, Balb/c CD4 T cells
retrovirally expressing the domain deletion mutants of Foxp3 were
isolated by FACS sorting and used as inhibitors in the in vitro inhibition assay, whereas CD4 T cells from congenic Balb/c.Thy.1.1 were

used as the responders. As the Foxp3 mutant-expressing CD4 T
cells themselves could undergo strong proliferation, instead of 3 Hthymidine incorporation we labeled the responder T cells with
CFSE, and measured cell proliferation/division by CFSE dilution in
the Thy1.1+ CD4 T cells.
As shown in Fig. 3A and B, in the absence of any inhibitors, large
percentages of the Thy1.1+ responder cells were in populations that
have undergone high numbers of divisions. As expected, strong
responder cell division was observed when CD4 T cells expressing only tag were used as “inhibitors”. However, the cell division
was not as robust as that of no inhibitor control. This was also
observed in our earlier study (Zeng et al., 2009), and was likely
due to steric hindrance of interaction between responder T cells
and APC by the “inhibitors”. When CD4 T cells expressing the wild
type Foxp3 were used as the inhibitors, a large percentage of the
responder cells remained undivided, and only small percentages of
cells showed high numbers of divisions. Again, as expected CD4 T
cells expressing the Fkh mutant lost the ability to inhibit responder T cell division. When CD4 T cells expressing the NT mutant
were used as inhibitors, the distribution patterns of the responder
cells were similar to that of CD4 T cells expressing the tag only as
inhibitors, i.e., relatively high percentages of cells in high divisions,
and low percentages in low divisions. When CD4 T cells expressing
the Zip mutant were used as inhibitors, division of the responder
T cells was somewhat decreased but the decrease was not statistically signiﬁcant. In contrast, when CD4 T cells expressing the ZnF
mutant were used as inhibitors, decrease of the responder T cell
division was much greater and was statistically signiﬁcant (Fig. 3A
and B). Nonetheless, the inhibition of responder T cell division by
the CD4 T cells expressing the zinc ﬁnger deletion mutant was not
as strong as that by CD4 T cells expressing the wild type Foxp3. Thus
the zinc ﬁnger deletion mutant partially retained inhibitory activity, demonstrating that the zinc ﬁnger domain is not as important
as the N-terminal and leucine zipper domains for the inhibitory
activity of Foxp3.

3.4. In vivo immune suppression in the IBD model
While the inhibition of responder T cell proliferation is an
in vitro assay of Treg cell and/or Foxp3 function, inhibition of IBD
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Fig. 3. Effects of domain deletion Foxp3 mutants on the inhibition of responder CD4 T cell proliferation in vitro. (A) CFSE dilution assays were carried out as described in
Material and Method. The inhibitor cells were Balb/c CD4 T cells retrovirally expressing tag only or the wild type or indicated mutant Foxp3 genes prepared as in Fig. 3.
Responder CD4 T cells were derived from Balb/c.Thy1.1 mice and labeled with CFSE. On day 4 of stimulation with anti-CD3 Ab plus APC, the cells were stained with APC
conjugated anti-CD4 Ab and PE-Cy5-conjugated anti-Thy1.1 Ab, then analyzed by ﬂow cytometry. Histograms of CFSE on gated CD4+ Thy.1.1+ cells are shown. Responder cells
maintained in medium plus IL-2 (CD4 + IL-2) were included as reference of nondividing cells. Responder CD4 T cells stimulated with anti-CD3 plus APC without inhibitors
(CD4 + APC) were also included. One of 3 independent experiments with similar results is shown. (B) Division indices are plotted using data pooled from the experiments in
(A). The p value of Student t test between the tag and ZnF groups is shown.

is widely used as an assay for Treg cell-mediated immune suppression in vivo (Hori et al., 2003; Powrie et al., 1994; Read and
Powrie, 2001). As described before (Powrie et al., 1994), we induced
IBD by adoptive transfer of CD4+ CD25− CD45RBhi cells into B.C17.Scid mice. Co-transfer of CD4 T cells retrovirally expressing the
wild type Foxp3 essentially prevented IBD as judged by the relatively lack of inﬂammatory inﬁltration and intact architecture of
the colon wall (Fig. 4A and B). In contrast, co-transfer of CD4 T cells
expressing the NT, Zip or Fkh mutant could not prevent IBD
as judged by the massive inﬂammatory inﬁltration and loss of the
architectural integrity of the colon wall (Fig. 4A and B). Although
signiﬁcant inﬂammatory inﬁltration was observed in mice received
co-transfer of CD4 T cells expressing the ZnF mutant, the level
of inﬁltration was clear reduced compared with those of the no
inhibitor control. Therefore, consistent with the result of the in vitro
inhibition assay, the ZnF mutant remained partially inhibitory in
the in vivo model of IBD.
3.5. Inhibition of T helper subset differentiation
Our recent studies have shown that high-level expression of
Foxp3 in CD4 Tcon cells can block Th2 cell differentiation, but has

only marginal effect on Th17 and no effect on Th1 cell differentiation (Zeng et al., 2009). Therefore, we wished to examine the
effects of domain deletion on Th2 cell differentiation. Since the
expression of retrovirally transferred gene can take up to 2 days,
to fully assess the effects of domain deletion we opted to retrovirally express the mutants in CD4 T cells before subjecting the cells
to Th polarizing signals. Thus CD4 T cells were stimulated under
neutral conditions and infected with retrovirus expressing the tag,
the wild type Foxp3 or the domain deletion mutants. At the end
of ﬁrst round of stimulation, the infected cells were isolated by
FACS and re-stimulated under Th1 or Th2 polarizing conditions.
The differentiated cells were analyzed for IFN-␥ and IL-4 expression by intracellular cytokine staining (Fig. 5). Consistent with our
previous report, wild type Foxp3 did not show any effect on IFN␥ expression after Th1 differentiation. Neither did we observe any
effects on Th1 differentiation by any of the domain deletion mutant.
After Th2 differentiation, T cells expressing the tag alone differentiated into Th2 cells (IL-4 single producing cells). However, Th2
differentiation from CD4 T cells expressing the wild type Foxp3
was greatly diminished. In contrast, substantial Th2 cell differentiation was observed in CD4 T cells expressing the NT, Zip or
Fkh mutant. In contrast, Th2 differentiation was substantially

Fig. 4. Adoptive transfer of CD4 T cells expressing Foxp3 domain deletion mutants to mice in the IBD model. (A) IBD was induced by adoptive transfer of Balb/c
CD4+ CD25− CD45RBhi cells into B.C-17.Scid mice. The recipient mice received either the CD4+ CD25− CD45RBhi cells alone or together with Balb/c CD4 T cells retrovirally
expressing the wild type or the indicated Foxp3 mutants. After 2 months, the colons of the recipient mice were analyzed by histology. H&E staining of the colons in 1
representative of 3 independent experiments is shown. (B) Colitis scores of individual mice (n = 6) of experiments in (A) are plotted. P value of Student t test between ZnF
and none inhibitors groups is shown.
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Fig. 5. Th1 (A) and Th2 (B) differentiation from CD4 T cells retrovirally expressing. Foxp3 domain deletion mutants. Balb/c CD4 T cells were stimulated with anti-CD3 plus
APC, and infected with retrovirus expressing the tag, the wild type or mutant Foxp3. After 1 week, the infected cells were isolated by FACS and restimulated with anti-CD3
Ab plus APC under Th1 or Th2 conditions for another week. The cells were then analyzed for IFN-␥ and IL-4 expression by intracellular cytokine staining. The cells were also
stained with PE-Cy5 conjugated anti-CD4 antibody. Dot plots of IFN-␥ and IL-4 staining in gated CD4+ GFP+ cells are shown. Numbers in the plots indicate the percentages of
each cell population. Two independent experiments are shown.

reduced in CD4 T cells expressing ZnF mutant, albeit the inhibition was not as strong as in cells expressing the wild type Foxp3.
Therefore, like in the other assays, the ZnF mutant behaved similarly to the wild type Foxp3 with reduced potency to inhibit Th2
differentiation.

3.6. Effects of domain deletion on Foxp3 DNA binding
The detailed molecular mechanisms or modes of action of Foxp3
in its various immune regulatory roles remain to be elucidated.
Nonetheless, DNA binding by Foxp3 via its forkhead domain is
necessary for Foxp3 to regulate gene expression (Li et al., 2007;
Lopes et al., 2006; Wu et al., 2006). We therefore investigated how
the domain deletion might affect the binding of Foxp3 to a wellcharacterized Foxp3 target DNA, the ARRE element of the murine
IL-2 gene promoter (Li et al., 2007; Lopes et al., 2006; Wu et al.,
2006). We performed ChIP assay to quantitatively determine the
binding of wild type and mutant Foxp3 to this site in vivo. As shown
in Fig. 6, we detected strong binding of the wild type Foxp3 to the
target site, but the binding was lost with the Fkh mutant consistent with earlier studies showing the essential role of this domain
for transcriptional repression by Foxp3 (Schubert et al., 2001). The
binding by the Zip was also greatly diminished. With NT and
ZnF mutants, we detected modest decrease of the binding. The
strong and mild effects of the deletion of leucine zipper and zinc
ﬁnger domains, respectively, on DNA binding are consistent with
earlier DNA binding studies using point mutation mutants (Koh
et al., 2009; Li et al., 2007).

4. Discussion
This report investigated the requirement of 3 domains of Foxp3,
the N-terminal region, the zinc ﬁnger and the leucine zipper
domains for the functions of Foxp3. As a control, we also studied the
forkhead domain. We deleted each of these domains to determine
their roles in Foxp3-mediated hypoproliferation of CD4 T cells,
immune suppression in vitro and in vivo, and down-regulation
of Th2 cell differentiation. Systematic analyses of such structurefunctional relation of Foxp3 have not been reported before. Our
studies showed that all 3 domains are required for the optimal functions of Foxp3. Nonetheless, among the 3 domains, the deletion of
the zinc ﬁnger domain showed relatively small effects on Foxp3
functions. Therefore, this region could be potential site for genetic
engineering of Foxp3 protein without overly altering the immune
regulatory functions of Foxp3.
In our studies, we chose to completely delete a domain. This
approach offers the advantage to fully assess the domain functions. In contrast, residual functions may be retained after point
mutation or small deletion of selected amino acids, especially if
the information to indicate which amino acids are functional critical is lacking. While mutagenesis is a powerful tool to study gene
function, a versatile and reliable method for deletion mutagenesis
has not been available. The widely used site-speciﬁc mutagenesis
methods (Deng and Nickoloff, 1992; Gillam et al., 1980) are effective for generating point mutation and small deletion/insertion, but
are not suitable for deletion or insertion of a large DNA segment. In
the past, investigators often had to rely on restriction digestion to
delete or insert a large DNA segment within a DNA fragment, and
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Fig. 6. ChIP analyses of the DNA binding activities of domain deletion Foxp3 mutants. CD4 T cells were retrovirally transduced with the indicated constructs. The infected cells
were stimulated with PMA and ionomycin. Chromatin fragments were pulled down with IgG-conjugated sepharose beads. DNA derived from the precipitated chromatins
were analyzed by real-time PCR using primers encompassing the murine IL-2 ARRE site. The ampliﬁcation signals were normalized to input chromatin DNA and relative
ampliﬁcation signals were determined by comparing to that of the tag samples. Results of 2 independent experiments are shown.

therefore the mutagenesis was limited by the availability of speciﬁc
restriction sites in the DNA sequence. To overcome these problems,
we designed a method of mutagenesis called the bridge-mediated
mutagenesis. This method allows for deletion (Fig. 1) or insertion
(Fig. S1) of a DNA segment of any size at any nucleotide positions
of a DNA fragment. It can also be used for point mutation (Fig. S1).
The key to successful application of this method is the low molar
concentration of the bridge oligo/fragment relative to the primers
in the second PCR, which favors the synthesis of the full-length
mutant.
In IPEX patients, most of the known mutations of Foxp3 are
located in the forkhead domain, some mutations were also found in
the leucine zipper and the N-terminal domains (Lopes et al., 2006;
Torgerson and Ochs, 2007). In contrast, no mutation in the zinc ﬁnger domain has been found in IPEX patients. Furthermore, a C204S
point mutation that disrupts the zinc ﬁnger structure revealed little consequences with regard to DNA binding and dimerization of
Foxp3 (Koh et al., 2009; Lopes et al., 2006). It must be pointed
out that the earlier study of the effect of the zinc ﬁnger on Foxp3
DNA binding was analyzed by gel shift experiments using optimized Foxp3 target oligonucleotide as probe (Koh et al., 2009).
Our study using the ChIP assay for binding to the endogenous IL2 ARRE target corroborated the earlier ﬁnding that this domain is
not essential for DNA binding. More importantly, we are the ﬁrst
to analyze the immunological functions of this domain. Its relatively mild effects on Foxp3 functions explain why mutation in this
domain may not lead to IPEX. Nonetheless, compared with wild
type Foxp3, the ZnF mutant did showed signiﬁcant reduction of
the functions of Foxp3. Therefore, the zinc ﬁnger domain is partially required for Foxp3 functions. It is reasonable to speculate that
mutations in this domain could be present in and even responsible
for less severe autoimmune and allergic diseases where only reduction rather than complete lack of Foxp3 functions is expected. Based
on such assumption, it is important to study this domain.
Unlike the deletion of the zinc ﬁnger domain, deletion of the
N-terminal or the leucine zipper domain essentially abolished the
functions of Foxp3 of controlling all three major features of the
Treg cells. Although the N-terminal domain has been shown to have
transcriptional repressor activity in promoter reporter assays and
is required for suppressing IL-2 expression in CD4 T cells (Bettelli
et al., 2005; Lopes et al., 2006; Wu et al., 2006), our studies represent a systematic analysis using the immunological assays to show
the functional signiﬁcance of this domain in Treg cell immunobiol-

ogy. On the other hand, a single amino acid deletion E251 in the
leucine zipper domain was found in IPEX patients. This mutation
impairs dimerization of Foxp3 (Chae et al., 2006; Li et al., 2007;
Lopes et al., 2006). An earlier study also found that no inhibition
of 3 H-thymidine incorporation in in vitro inhibition assay using
the CD4 T cells expressing the E251 mutant as inhibitors (Chae
et al., 2006). However, since the “inhibitors” in this study also
incorporated 3 H-thymidine, it is difﬁcult to distinguish whether
the high incorporation of 3 H-thymidine was due to proliferation
of the “inhibitors” or the lack of inhibition of the proliferation of
the responders. Using the CFSE assay, we unambiguously demonstrated that there was no (or only minimal) inhibition of responder
cell proliferation by the CD4 T cells expressing the Zip mutant.
We further demonstrated the loss of in vivo immune suppression
by this mutant using the IBD model.
The systematic approach used in our studies also allowed us to
determine whether the domains of the Foxp3 function in a modular
fashion or in unison to regulate the different immunological features of the Treg cells. Gene proﬁling studies have shown that Foxp3
controls the expression of a large number of genes in Treg cells by
either up or down regulation (Hill et al., 2007; Zheng et al., 2007).
If the domains function in a modular fashion, the deletion mutants
could be used to categorize which groups of genes regulated by
Foxp3 are important for which of the different features of the Treg
cells. However, our data showed that deletion of any of these 3
domains had similar effects on all 3 features of the Treg cells. Therefore, the domains of the Foxp3 must function together to deﬁne
the immunological features of Treg cells. However, the detailed
modes of action of Foxp3 for regulating the different features of
the Treg cells remain to be elucidated, and are beyond the scope
of the current study. Nonetheless, our DNA binding studies support the notion that the domains outside the forkhead domain can
strengthen the DNA binding activity of Foxp3 but also have other
functions. For example, the deletion of the N-terminal domain only
partially affected Foxp3 DNA binding, but completely abolished the
immunological functions of Foxp3. In addition to the weakening of
DNA binding, the loss of functions in this mutant could be due to
the loss of the independent repressor activity (Lopes et al., 2006)
or other regulatory activities of the N-terminal domain.
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